Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/01/2019 | 02:55am EST

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]
Fresenius Medical Care AG & Co. KGaA: Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

01.11.2019 / 08:53
Dissemination of a Post-admission Duties announcement according to Article 50 Para. 1, No. 2 WpHG transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Medical Care AG & Co. KGaA has filed its report on Form 6-K
for the 3rd quarter 2019 with the U.S. Securities and Exchange Commission (SEC). The report is available on the website
https://www.freseniusmedicalcare.com/en/home/investors/news-publications/financial-reports/.


01.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

902257  01.11.2019 

fncls.ssp?fn=show_t_gif&application_id=902257&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
02:55aFRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
12/02FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/29FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
11/25FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/18FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/11FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS : Buys Colombia's CediMed in EUR40 Million Investment
DJ
11/01FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
10/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
More news
Financials (USD)
Sales 2019 19 366 M
EBIT 2019 2 553 M
Net income 2019 1 311 M
Debt 2019 12 365 M
Yield 2019 1,79%
P/E ratio 2019 16,5x
P/E ratio 2020 13,9x
EV / Sales2019 1,75x
EV / Sales2020 1,61x
Capitalization 21 496 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 85,89  $
Last Close Price 71,98  $
Spread / Highest target 54,4%
Spread / Average Target 19,3%
Spread / Lowest Target -32,3%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer